Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Enveric Biosciences Beat Earnings?

Enveric Biosciences (ENVB) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Enveric Biosciences’s job postings, web traffic, and employee business outlook. See the full ENVB stock analysis or the earnings calendar for upcoming reports.

Enveric Biosciences Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue—340,000——————
Gross margin—-24.2%——————
Operating margin—-932.4%——————
Net income-2.1M-3.2M-2.2M-2.5M-1.9M-2.2M-1.6M-3M
Net margin—-926.8%——————
EPS————————

Enveric Biosciences Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Enveric Biosciences’s quarterly revenue moved from $0 to $0.

When Is Enveric Biosciences’s Next Earnings Date?

Enveric Biosciences reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the ENVB earnings calendar.

Frequently Asked Questions: Enveric Biosciences Earnings

Enveric Biosciences's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Enveric Biosciences reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ENVB AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.